🔴 Moleculin Biotech is trading 35% down today after pricing $9.3M public offering at a steep discount

Moleculin Biotech is trading 35% down at $0.29 after pricing a $9.3 million public offering at a steep discount to recent market levels.

• The offering, priced at $0.75 per share with attached warrants, has fueled a multi-day collapse from prices above $2.00 last week.
• The deal is expected to close around August 3, with the stock facing heavy pressure from dilution fears and weak investor sentiment.